Silexion Therapeutics Ltd.SLXNNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank100
Year-over-Year Change
Year-over-year research & development expense growth
Latest
56.82%
↑ 296% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthAccelerating
Average
14.35%
Historical baseline
| Period | Value |
|---|---|
| 2024 | 56.82% |
| 2023 | 14.94% |
| 2022 | 0.00% |
| 2021 | 0.00% |
| 2020 | 0.00% |